Marusic 2018.

Methods	RCT
Participants	Inclusion: ≥ 18 years old, T2DM diagnosis, hospital discharge to the community Exclusion: cognitive disorders, terminal illness (< 1 month life expectancy), transfer to other hospital or discharge to a long‐term care facility, refusal to participate
Interventions	Intervention: participants received additional 30‐minute individual pre‐discharge pharmacotherapeutic education by a qualified physician about discharge medication (indications, dosage, administration, importance of adherence, and possible adverse drug reactions). Participants were given the same information in writing Control: usual care Both groups during the hospital stay received standardised diabetes education, including education about the disease, diet, physical activity, alcohol intake, smoking, diabetes medications, glucose self‐monitoring, and acute and chronic diabetes complications
Outcomes	Medication adherence using pill count, adverse drug reactions, hospital re‐admissions, emergency department visits, and mortality
Notes	NCT03438162; completed trial Note: median age 72/71, mean number of prescribed drugs 7.5/7.3